Transitions

Dan Erlanson
Additional contact information
Dan Erlanson: Dan Erlanson is a chemist and the co-founder of a company that is still focused on drug discovery.

Nature, 2010, vol. 464, issue 7285, 132-132

Abstract: Different business models for difficult times.

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/464132a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:464:y:2010:i:7285:d:10.1038_464132a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/464132a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().